COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

Yearly Archives:
2013

18

December
2013

category:

503b Compounding

Today’s Shortages

ASHP/FDA Sincalide Inj.

read more

17

December
2013

category:

503b Compounding

Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy

SILVER SPRING, Md., Dec. 17, 2013 /PRNewswire/ — Pharmagen, Inc. (OTCBB: PHRX) (the “Company” or “Pharmagen”) announces that is has executed an agreement with Bagel Boy Equity Group II, LLC, whereby its Managing Partner, Richard A. Wolpow will become Chairman of the Board of Directors and interim Chief Operating Officer (“COO”). Wolpow will work closely […]

read more

17

December
2013

category:

503b Compounding

Landmark legislation enacted to improve the safety of drugs distributed and used in the United States

On November 27, President Barack Obama signed the Drug Quality and Security Act (H.R. 3204), a law that makes significant changes that will have a widespread effect on all members of the US prescription drug supply chain – from manufacturers and wholesale distributors to retail pharmacies and large-scale drug compounding operations. The law consists of […]

read more